跳至主導覽 跳至搜尋 跳過主要內容

A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma

  • Chun Ta Liao
  • , Jason Chia-Hsun Hsieh
  • , Wen Lang Fan
  • , Shu Hang Ng
  • , Nai Ming Cheng
  • , Li Yu Lee
  • , Chuen Hsueh
  • , Chien Yu Lin
  • , Kang Hsing Fan
  • , Hung Ming Wang
  • , Chih Hung Lin
  • , Chung Kan Tsao
  • , Chung Jan Kang
  • , Tuan Jen Fang
  • , Shiang Fu Huang
  • , Kai Ping Chang
  • , Li Ang Lee
  • , Ku Hao Fang
  • , Yu Chien Wang
  • , Lan Yan Yang*
  • Tzu Chen Yen
*此作品的通信作者
  • Chang Gung Memorial Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

8 引文 斯高帕斯(Scopus)

摘要

Objective: Clinical outcomes of patients with resected oral cavity squamous cell carcinoma (OCSCC) chiefly depend on the presence of specific clinicopathological risk factors (RFs). Here, we performed a combined analysis of FDG-PET, genetic markers, and clinicopathological RFs in an effort to improve prognostic stratification. Methods: We retrospectively reviewed the clinical records of 2036 consecutive patients with first primary OCSCC who underwent surgery between 1996 and 2016. Of them, 345 underwent ultra-deep targeted sequencing (UDTS, between 1996 and 2011) and 168 whole exome sequencing (WES, between 2007 and 2016). Preoperative FDG-PET imaging was performed in 1135 patients from 2001 to 2016. Complete data on FDG-PET, genetic markers, and clinicopathological RFs were available for 327 patients. Results: Using log-ranked tests based on 5-year disease-free survival (DFS), the optimal cutoff points for maximum standardized uptake values (SUV-max) of the primary tumor and neck metastatic nodes were 22.8 and 9.7, respectively. The 5-year DFS rates were as follows: SUVtumor-max ≥ 22.8 or SUVnodal-max ≥ 9.7 (n = 77) versus SUVtumor-max < 22.8 and SUVnodal-max < 9.7 (n = 250), 32%/62%, P < 0.001; positive UDTS or WES gene panel (n = 64) versus negative (n = 263), 25%/62%, P < 0.001; pN3b (n = 165) versus pN1-2 (n = 162), 42%/68%, P < 0.001. On multivariate analyses, SUVtumor-max ≥ 22.8 or SUVnodal-max ≥ 9.7, a positive UDTS/WES gene panel, and pN3b disease were identified as independent prognosticators for 5-year outcomes. Based on these variables, we devised a scoring system that identified four distinct prognostic groups. The 5-year rates for patients with a score from 0 to 3 were as follows: loco-regional control, 80%/67%/47%/24% (P < 0.001); distant metastases, 13%/23%/55%/92% (P < 0.001); DFS, 74%/58%/28%/7% (P < 0.001); and disease-specific survival, 80%/64%/35%/7% (P < 0.001) respectively. Conclusions: The combined assessment of tumor and nodal SUV-max, genetic markers, and pathological node status may refine the prognostic stratification of OCSCC patients.

原文英語
頁(從 - 到)84-93
頁數10
期刊European Journal of Nuclear Medicine and Molecular Imaging
卷47
發行號1
DOIs
出版品狀態已出版 - 01 01 2020

文獻附註

Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma」主題。共同形成了獨特的指紋。

引用此